Hereditary ATTR Amyloidosis: Educational Overview

This program is intended for people interested in learning about hATTR amyloidosis, including individuals diagnosed with hATTR amyloidosis, their families, and caregivers.
Speakers:
Kathy (Patient Education Liaison, Alnylam Pharmaceuticals)
Jean (Living with hATTR amyloidosis)
David Avila, MD (Neurologist & Clinical Assistant Professor, Geisinger Medical Center)
Date & Time:
Wednesday, April 13, 2022
01:00 PM Eastern Daylight Time
Duration:
1 hour, 30 minutes

This event has ended.